Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYTO -- Ignore unavailable to you. Want to Upgrade?

To: Jim Oravetz who wrote (7422)	12/15/1998 8:58:00 PM
From: Jim Oravetz	Respond to of 8116

I found this from last Friday 12/11 News: Cytogen Corp Registers 8M Common Shares For Sale (CYTO) (NewsTraders.com)-- Cytogen Corp. (CYTO) filed with the SEC this afternoon to register 8 million shares of common stock, according to a Form S-1. Cytogen, which said it would sell the shares from time to time on its own behalf, intends to use the net proceeds from any sale of the shares to support corporate development initiatives, including expansion of corporate programs and opportunities and marketing programs. According to the company's most-recent quarterly report, Cytogen had 58.6 million common shares outstanding as of October 26. Based in Princeton, N.J., Cytogen is a biopharmaceutical company engaged in the development, commercialization and marketing of products to improve diagnosis and treatment of cancer and other diseases. Copyright 1998 NewsTraders Inc. All Rights Reserved Friday, December 11, 1998